Cargando…
Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature
Camurati-Engelmann Disease (CED) is a rare sclerosing bone disease, sometimes associated delayed puberty. The treatment effect of glucocorticoid and angiotensin II receptor blocker (ARB) in bone health and puberty development remain unclear. We report a case of an 18-year-old girl who presented for...
Autores principales: | Cui, Lijia, Li, Qian, Guan, Wenmin, Yu, Wei, Li, Xiang, Xia, Weibo, Jiang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247158/ https://www.ncbi.nlm.nih.gov/pubmed/35784539 http://dx.doi.org/10.3389/fendo.2022.882144 |
Ejemplares similares
-
Losartan improves clinical outcome in Camurati Engelmann Disease
por: Ayyavoo, Ahila, et al.
Publicado: (2013) -
Camurati-Engelmann Disease with Good Treatment Response to Losartan
por: Abdulla, Mansoor Cherumkuzhiyil
Publicado: (2019) -
Clinical characteristics and the influence of rs1800470 in patients with Camurati-Engelmann disease
por: Liang, Hanting, et al.
Publicado: (2022) -
Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease
por: Agarwal, Khushboo, et al.
Publicado: (2021) -
Regarding Camurati-Engelmann Disease: To the Editor
por: Viana, Melissa Machado, et al.
Publicado: (2018)